Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
SupplySide WestSupplySide West
Not Confirmed
Not Confirmed
27-30 October, 2025
Oncology ResearchOncology Research
Not Confirmed
Not Confirmed
29-30 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
SupplySide WestSupplySide West
Industry Trade Show
Not Confirmed
27-30 October, 2025
Oncology ResearchOncology Research
Industry Trade Show
Not Confirmed
29-30 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

22 Oct 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/regeneron-settles-eylea-patent-dispute-celltrion-allowing-another-biosimilar-launch-2026

17 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-approves-expanded-pediatric-indications-for-yuflyma-adalimumab-aaty-and-unbranded-adalimumab-aaty-in-the-united-states-302587319.html

09 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/celltrion-receives-us-fda-approval-for-eydenzelt-aflibercept-boav-biosimilar-referencing-eylea-aflibercept-302580323.html

06 Oct 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-10-06/celltrion-presents-positive-real-world-data-on-switching-from-intravenous-iv-to-subcutaneous-sc

06 Oct 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-10-06/hikma-and-celltrion-strengthen-partnership-to-expand-biosimilar-access-in-mena

02 Oct 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761377
ABOUT THIS PAGE
Celltrion is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Infliximab bulk with JDMF offered by Celltrion
Find a price of Trastuzumab bulk with JDMF offered by Celltrion
Find a price of Infliximab bulk offered by Celltrion